These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27102863)

  • 1. Clinicopathological significance and diagnostic accuracy of HER2 immunohistochemistry in colorectal cancer: a meta-analysis.
    Pyo JS; Kang G; Park K
    Int J Biol Markers; 2016 Dec; 31(4):e389-e394. PubMed ID: 27102863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance rate between HER2 immunohistochemistry and in situ hybridization in gastric carcinoma: systematic review and meta-analysis.
    Pyo JS; Sohn JH; Kim WH
    Int J Biol Markers; 2016 Feb; 31(1):e1-10. PubMed ID: 26349670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance analysis between HER2 immunohistochemistry and in situ hybridization in non-small cell lung cancer.
    Ko YS; Kim NY; Pyo JS
    Int J Biol Markers; 2018 Jan; 33(1):49-54. PubMed ID: 28478639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
    Wu SW; Ma CC; Li WH
    Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of BRAF Immunohistochemistry in Colorectal Cancer: a Meta-Analysis and Diagnostic Test Accuracy Review.
    Pyo JS; Sohn JH; Kang G
    Pathol Oncol Res; 2016 Oct; 22(4):831-7. PubMed ID: 27197524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance and concordance analysis of c-MET immunohistochemistry in non-small cell lung cancers: A meta-analysis.
    Pyo JS; Kang G; Cho WJ; Choi SB
    Pathol Res Pract; 2016 Aug; 212(8):710-6. PubMed ID: 27465837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in HER2 expression between primary colorectal cancer and corresponding metastases.
    Shan L; Lv Y; Bai B; Huang X; Zhu H
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2275-2281. PubMed ID: 30203148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH.
    Buhmeida A; Assidi M; Al-Maghrabi J; Dallol A; Sibiany A; Al-Ahwal M; Chaudhary A; Abuzenadah A; Al-Qahtani M
    Cancer Invest; 2018 Feb; 36(2):129-140. PubMed ID: 29504811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in-situ hybridisation.
    Koopman T; van der Vegt B; Dijkstra M; Bart J; Duiker E; Wisman GBA; de Bock GH; Hollema H
    Histopathology; 2018 Nov; 73(5):852-863. PubMed ID: 29989198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
    Li JW; Chuang TC; Yang AH; Hsu CK; Kao MC
    Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis.
    Pyo JS; Kang G; Cho H
    J Gastric Cancer; 2016 Sep; 16(3):141-151. PubMed ID: 27752391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value.
    Seo AN; Kwak Y; Kim WH; Kim DW; Kang SB; Choe G; Lee HS
    Virchows Arch; 2015 Jun; 466(6):645-54. PubMed ID: 25739551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression.
    Seo AN; Kwak Y; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    PLoS One; 2014; 9(5):e98528. PubMed ID: 24879338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Her2/neu status in colorectal carcinoma and clinicopathological features: a retrospective study using whole - tissue sections.
    Kılıçarslan A; Dogan HT; Süngü N; Dogan M; Yalcin A; Dede DŞ
    Pol J Pathol; 2018; 69(2):143-149. PubMed ID: 30351861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancer.
    Tsai YF; Tseng LM; Lien PJ; Hsu CY; Lin YS; King KL; Wang YL; Chao TC; Liu CY; Chiu JH; Yang MH
    Histopathology; 2019 Mar; 74(4):578-586. PubMed ID: 30515868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria.
    Sun Q; Li Q; Gao F; Wu H; Fu Y; Yang J; Fan X; Cui X; Pu X
    J Cancer Res Clin Oncol; 2023 Feb; 149(2):579-592. PubMed ID: 36018511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlated non-nuclear COX2 and low HER2 expression confers a good prognosis in colorectal cancer.
    Zhou FF; Huang R; Jiang J; Zeng XH; Zou SQ
    Saudi J Gastroenterol; 2018; 24(5):301-306. PubMed ID: 29873317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene protein detection platform--a comparison of a new human epidermal growth factor receptor 2 assay with conventional immunohistochemistry and fluorescence in situ hybridization platforms.
    Stålhammar G; Farrajota P; Olsson A; Silva C; Hartman J; Elmberger G
    Ann Diagn Pathol; 2015 Aug; 19(4):203-10. PubMed ID: 25921313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
    Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
    World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.